Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Maia Oncology
AddedFeb 17, 2024
UpdatedJun 18, 2026
Maia Oncology

Maia Oncology

Seed

NYC-based Maia Oncology provides onco-primary care for cancer patients and survivors.

HQ
New York City, NY, US
Founded
2023
Overview
Compare
Fundraising
Employees
Website

Founded in New York City, Maia Oncology is the first virtual comprehensive primary care clinic dedicated to cancer patients and survivors. Their core mission is to manage the complex long-term complications and toxicities that arise from cancer treatments, ensuring that patients do not face these challenges alone. Maia Oncology offers specialized onco-primary care services, focusing on the unique healthcare needs of individuals who have undergone cancer treatment.

Notable affiliated people and investors include leading oncologists and healthcare innovators committed to improving cancer survivorship care. Key achievements include pioneering a virtual care model that provides accessible, continuous support for cancer survivors nationwide. Maia Oncology's impact lies in its innovative approach to addressing the often-overlooked post-treatment phase, significantly enhancing the quality of life for cancer survivors.

Maia Oncology - Similar Companies

OncoHealth logo

OncoHealth

oncohealth.us

VivorCare logo

VivorCare

vivorcare.com

Massive Bio logo

Massive Bio

massivebio.com

cancerGO logo

cancerGO

Haploscope logo

Haploscope

haploscope.com

Navigating Cancer logo

Navigating Cancer

Robin Care logo

Robin Care

Liyfe logo

Liyfe

OncoPrecision logo

OncoPrecision

oncoprecision.bio

The Oncology Institute logo

The Oncology Institute

Onc.AI logo

Onc.AI

onc.ai

Onko Solutions logo

Onko Solutions

Regional Cancer Care Associates logo

Regional Cancer Care Associates

Oncospace logo

Oncospace

oncospace.com

Oncology Honduras logo

Oncology Honduras

Maia Oncology - Quick Facts

Who are Maia Oncology's competitors?

Companies similar to Maia Oncology include OncoHealth, VivorCare, Massive Bio and cancerGO.

When was Maia Oncology founded?

Maia Oncology was founded in 2023.

Where is Maia Oncology's headquarters located?

Maia Oncology's headquarters is located in New York City, NY, US.

When was Maia Oncology's last funding round?

Maia Oncology's most recent funding round was for $4.3M (USD) in November 2023.

How much has Maia Oncology raised to-date?

As of Nov 26, 2023, Maia Oncology has raised a total of $4.3M (USD).

How many employees does Maia Oncology have?

Maia Oncology has 5 employees as of Feb 4, 2024.

Maia Oncology - Classification

Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Consumers
Main Product
  • Oncology Care
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified